Ramping up vaccine manufacturing in Africa

Ramping up vaccine manufacturing in Africa.

Today, less than 1% of vaccines used in Africa are manufactured locally. This means that African countries are reliant on imports to immunize their people, including against long-standing diseases like polio and newer scourges like COVID-19.

The latest episode in the Mission Imagination series features Mr. Patrick Tippoo, Chief Science and Innovation Officer at South Africa-based Biovac and Executive Director of the African Vaccine Manufacturing Initiative (AVMI), which advocates for the establishment of vaccine development and manufacturing capacity in Africa.